Amid a series of market shifts, Bio-Techne Corp [TECH] continues to display resilience. The bio-technology entity's Q3 2025 financial results announcement event is scheduled for May 7, 2025, driving investors' anticipation. In a bid to improve its worldwide customer service, the firm announced the unveiling of a new Customer Experience Centre in Düsseldorf, Germany.
Notwithstanding the company's stock hitting a 52-week low at some point, it has maintained a strong momentum in recent times. This owes largely to strategic expansions, such as the extension of RNAscope menu and its partnership with Waters Corporation, which are proving beneficial. The recent appointment of Dr. Amy E. Herr to the board signifies strengthened leadership. The launch of TcBuster, a pioneering non-viral genome engineering system, reflects innovation.
Indeed, despite some industry setbacks, the upsides outweigh the lows. Bio-Techne's unveiling of GMP TcBuster, its new distribution deals with Leader Life Sciences and Medsantek, and strategic investment in Spear Bio underline its aggressive growth strategy. Lastly, Bio-Techne Corp emerged as one of the best of the bunch in Q4 earnings within the Research Tools & Consumables Stocks segment.
Bio-Techne Corp TECH News Analytics from Fri, 18 Nov 2022 08:00:00 GMT to Thu, 17 Apr 2025 15:01:30 GMT - Rating 6 - Innovation 4 - Information 6 - Rumor -4
